Els M. Berns
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 91 publications
Unveiling Candidate Markers for Drug Resistance or Synthetic Lethality in Cervical Cancer: Integrative Analysis of Genetic and Pharmacoprofiling.
Journal: Cancer reports (Hoboken, N.J.)
Published: March 18, 2026
Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.
Journal: British journal of cancer
Published: April 13, 2023
Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 16, 2021
Corrigendum to 'clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome'.
Journal: EBioMedicine
Published: July 11, 2020
Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.
Journal: British journal of cancer
Published: March 18, 2020
Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome.
Journal: EBioMedicine
Published: March 02, 2019
Patient-derived cell line models revealed therapeutic targets and molecular mechanisms underlying disease progression of high grade serous ovarian cancer.
Journal: Cancer letters
Published: February 22, 2019
A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 21, 2017
Last Updated: 09/26/2026